MedPath

BioGend Therapeutics Co., Ltd.

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

The Clinical Outcome of BiCRI in the Treatment of Chondral and Osteochondral Lesions

Not Applicable
Recruiting
Conditions
Articular Cartilage Disorder of Knee
Interventions
Device: Biphasic Cartilage Repair Implant (BiCRI)
First Posted Date
2023-06-29
Last Posted Date
2023-06-29
Lead Sponsor
BioGend Therapeutics Co.Ltd
Target Recruit Count
60
Registration Number
NCT05924763
Locations
🇨🇳

En Chu Kong Hospital, New Taipei City, Taiwan

OIF/β-TCP in Patients With Open Tibial Fractures in Need of Bone Grafting

Not Applicable
Active, not recruiting
Conditions
Tibia Fracture
Interventions
Device: OIF/β-TCP
First Posted Date
2021-07-14
Last Posted Date
2024-04-24
Lead Sponsor
BioGend Therapeutics Co.Ltd
Target Recruit Count
35
Registration Number
NCT04960722
Locations
🇨🇳

BioGend Therapeutics, Taipei, Taiwan

BiPhasic Cartilage Repair Implant (BiCRI) IDE Clinical Trial - Taiwan

Not Applicable
Completed
Conditions
Chondral or Osteochondral Lesion of Medial Femoral Condyle
Chondral or Osteochondral Lesion of Lateral Femoral Condyle
Chondral or Osteochondral Lesion of Trochlea
Interventions
Device: BiPhasic Cartilage Repair Implant
Procedure: Marrow Stimulation
First Posted Date
2011-11-22
Last Posted Date
2022-01-20
Lead Sponsor
BioGend Therapeutics Co.Ltd
Target Recruit Count
92
Registration Number
NCT01477008
Locations
🇨🇳

Chang Gung Memorial Hospital Kaohsiung (CGMH-KS), Kaohsiung, Taiwan

🇨🇳

Shuang Ho Hospital (SHH), Taipei, Taiwan

🇨🇳

China Medical University Hospital (CMUH), Taichung, Taiwan

and more 8 locations
© Copyright 2025. All Rights Reserved by MedPath